Physician

Nathan B Green, DO

According to 2025 Medicare claims, Nathan Green, DO (NPI: 1679563936) practices medical oncology in the Lincoln, NE market, with the plurality of this provider's patient population coming from Lancaster, NE. This provider's primary affiliated billing organization is CANCER PARTNERS OF NEBRASKA PC (NPI: 1437111408; TIN: 911862785) and primary practice location at 68516-5587. Green is affiliated with the NPG Health Collaborative LLC (ACO ID: A3287), Bryan Health Connect ACO, LLC (ACO ID: A4573), Caravan Collaborative Pathways (ACO ID: A4604), and Aledade 149 Regional MSSP (ACO ID: A5231), participating under the MSSP model.

Green's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,018 traditional Medicare patients, billed 164,968 HCPCS/CPT codes, and received $2,685,863 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,245 prescription claims across 243 beneficiaries totaling $2,264,628 in drug costs, led by Revlimid (Lenalidomide). DME data shows 29 claims. Open Payments data shows 103 records totaling $9,075. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,407,667 and ending at $2,264,628. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $8,866 and ending at $15,776.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,140	181,235	$2,710,519
2016	1,056	141,392	$2,626,070
2017	1,133	143,034	$2,935,775
2018	1,019	436,052	$3,926,638
2019	1,257	237,719	$3,711,092
2020	1,080	234,937	$3,205,694
2021	1,075	173,858	$2,529,837
2022	1,025	183,851	$2,432,219
2023	1,125	156,937	$2,202,811
2024	1,018	164,968	$2,685,863

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	228	1,524	$1,407,667
2016	221	1,631	$2,132,714
2017	237	1,495	$2,112,419
2018	225	1,352	$2,579,617
2019	213	1,300	$2,135,302
2020	231	1,392	$1,621,996
2021	246	1,288	$1,466,431
2022	247	1,256	$2,040,756
2023	236	1,287	$2,323,001
2024	243	1,245	$2,264,628

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	36	335	$73,708
2016	47	323	$72,189
2017	41	307	$67,442
2018	26	164	$16,274
2019	15	130	$9,578
2020	49	160	$9,829
2021	59	221	$133,209
2022	12	87	$2,882
2023	41	103	$8,468
2024	23	29	$2,189

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	470	1,143	$84
80053	Blood test, comprehensive group of blood chemicals	564	1,060	$10
36415	Insertion of needle into vein for collection of blood sample	561	1,178	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	638	1,478	$8
83615	Lactate dehydrogenase (enzyme) level	445	842	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	22	609	$386,111
Ibrance	Palbociclib	21	588	$331,752
Venclexta	Venetoclax	35	949	$310,312
Pomalyst	Pomalidomide	11	308	$236,907
Tagrisso	Osimertinib Mesylate	11	330	$187,399

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	23	29	$2,189

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	101	$1,575	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$7,500	Celgene Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nathan B. Green, DO?

Tedicare shows public-source Medicare data for Nathan B. Green, DO (NPI 1679563936), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nathan B. Green, DO have ACO affiliation data?

Nathan B. Green, DO is shown with ACO affiliation data for NPG Health Collaborative LLC (MSSP, ACO ID A3287), Bryan Health Connect ACO, LLC (MSSP, ACO ID A4573), Caravan Collaborative Pathways (MSSP, ACO ID A4604), and Aledade 149 Regional MSSP (MSSP, ACO ID A5231).

What billing organization is linked to Nathan B. Green, DO?

Nathan B. Green, DO is linked to CANCER PARTNERS OF NEBRASKA PC (billing NPI 1437111408) in the available physician profile data.

Does Nathan B. Green, DO have Open Payments data?

Nathan B. Green, DO has 103 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.